VALEANT PHARMACEUTICALS INTL

VRX stock holders 13F

7 superinvestors reported owning VRX (Common Stock) according to the gurus' 2016 Q1 reports.

Top 5 gurus who own (VRX) VALEANT PHARMACEUTICALS INTL

The top 5 super investors (holders) owning VRX (by the percentage (%) of portfolio) are Bill Ackman - Pershing Square Capital Management (6.41%), Francis Chou - Chou Associates Management (6.19%), Jeffrey Ubben - ValueAct Holdings (3.94%), Glenn Greenberg - Brave Warrior Advisors (2.61%) and Bill Miller - Miller Value Partners (2.06%) as of their 2016 Q1 reports.

To check the latest activities of the top VRX shareholders between value investors, please click on the "Activity" tab.

To see the historical data of VRX's holders please click on the "2016 Q1" dropdown menu and select the date.

# of holders: 7
Period: 2016 Q1
Type: Common Stock
Bill Ackman
6.41%
21,591,122
$26.30
$567,847,000
+30.14% (+5,000,000)
+1.49%
Bill Miller
2.06%
1,580,950
$26.30
$41,579,000
buy
+2.06%
David Tepper
0.50%
945,000
$26.30
$24,854,000
buy
+0.50%
Francis Chou
6.19%
976,843
$26.33
$25,725,000
buy
+6.19%
Glenn Greenberg
2.61%
2,034,281
$26.30
$53,502,000
-67.46% (-4,218,050)
-5.41%
Jeffrey Ubben
3.94%
14,994,261
$26.30
$394,349,000
Ravenel Boykin Curry IV
0.65%
5,898,545
$26.30
$155,132,000
-16.14% (-1,135,554)
-0.12%
AVG reported hold price*: $26.31

Completely sold out

Francois Rochon
127,735
-2.55%
Ole Andreas Halvorsen
7,793,397
-3.49%
Stephen Mandel
5,829,079
-3.02%

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.